: The clinical practice guidelines for the management of chronic obstructive pulmonary disease (COPD) included in this review.
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Chronic Obstructive Pulmonary Disease: Official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care 2013 Czech Republic [29] Diagnosis and Management of Chronic Obstructive Pulmonary Disease: The Swiss Guidelines 2013 Switzerland [30] 慢性阻塞性肺疾病诊治指南 (2013 年修订版 Portugal [34] (COPD national academic policy and guidelines for prevention, diagnosis, and care) 2012 Norway [35] Chronic Obstructive Pulmonary Disease 2012 Michigan: USA [36] PCO Prise en Charge De la Broncho-Pneumopathie Chronique Obstructive Guide pratique à l'usage du praticien (Chronic Obstructive Pulmonary Practice Guide for the Practitioner) 2012 Algeria [14] Danske KOL-Guideline (Danish COPD guideline) 2012 Denmark [37] Recomendaciones para la prevención, diagnóstico y tratamiento de la epoc en la Argentina (Recommendations for the prevention, diagnosis, and treatment of COPD in Argentina) 2012 Argentina [38] Diagnosis [39] Guideline for the management of Chronic obstructive pulmonary disease-2011 update 2011 South Africa [40] Chronic obstructive pulmonary disease (COPD) 2011 BC: Canada [41] Guía de práctica clínica Diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica(Clinical Practice Guideline Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease) 2011 Mexico [42] 5
Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care 2010 United Kingdom [43] Richtlijn Diagnostiek en behandeling van COPD (Guideline for the diagnosis and treatment of COPD) In section Palliation and End of Life Issues, "The World Health Organisation defines palliative care as an approach that improves the quality of life of patients and their families facing the problem associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual." p. 71
Palliative care for management and assessment (non-specific)
In section Confirm Exacerbation and Categorise Severity, Arterial Blood Gas, "The primary reasons for preferring VBG (over ABG) samples cited by the authors were less pain and lower risk of bruising." p. 100
Lung function testing indication/contraindication NHG:
In section Diagnosis, "In the case of differential diagnosis between COPD and heart failure, pay attention to cardiovascular risk factors or conditions in the history, such as hypertension, a myocardial infarction or angina pectoris, and ask for topical complaints, such as palpitations or chest pain that fits angina pectoris."
Physician visit to assess for differential diagnosis (chest pain)
In section Evaluation, "In differential diagnostics, the following conditions are particularly important: * Lung carcinoma; their suspicion may be based on symptoms (haemoptysis, altered cough pattern, chest pain, weight reduction) or on a chance finding on a chest X-ray…."
Physician visit to assess for differential diagnosis (chest pain) • preventing and alleviating pain and other symptoms, taking into account psychological, social and spiritual needs, respecting the dignity of the person being cared for;
• limit the occurrence of complications, by developing customized prescriptions;
• limit the breaks in care by ensuring the good coordination between the different actors of care." p. 28
Palliative care for management
In In section COPD Diagnosis, "Patients who are suspected of COPD should also be asked about the following factors: …Is there a chest pain? … Note: The last two symptoms are uncharacteristic for COPD and, in their presence, the probability of another disease increases." p. 18
Norway [35] 2012
In section Other Diseases, "Diseases that may give similar symptoms as COPD and which must be ruled out are heart failure, pulmonary artery disease (sarcoidosis, pulmonary fibrosis), sequela after tuberculosis, cystic fibrosis and tumors of the trachea and main bronchi. In exertion-related chest pain in addition to shortness of breath, coronary heart disease must be considered, while hemoptysis may include acute respiratory infection, pneumonia, lung cancer or pulmonary embolism." p. 31
In section Laboratory Test, "The test (cardiopulmonary exercise test) can tell whether it is the cardiocirculatory system, lung function, weight, ventilation/hypoxia/hypercapnia, peripheral muscle, pain in the musculoskeletal system, motivation/anxiety or irregular breathing patterns, or various combinations of these factors that explain a person's functioning." p. 53
CPET for pain assessment as exercise limitation
In section Secretion Mobilisation, Techniques for Secretion Mobilisation, Positive Expiratory Pressure (PEP), "For PEP the respiratory tract is kept open during the exhalation and increased pressure with improved air supply to the alveoli can contribute to stretch expansion of atelectatic lung tissue. In practice, PEP is a suitable aid for patients with difficulty to increase ventilation due to low level of function, overweight, pronounced fatigue or pain in the thorax." p. 55
Alternative management strategy for patients with pain
In section Systemic Drug Therapy, Phosphodiesterase Inhibitors (PDE4), "The most common side effects are nausea, abdominal pain, diarrhoea, sleep disorders and headaches. The side effects are early treatment is reversible and may decrease with prolonged use." p. 86
Drug adverse effects (phosphodiesterase-4 inhibitors)
In section Osteoporosis and Fractures, "COPD patients are at increased risk of osteoporosis and fracture. In patients with severe COPD have almost 70% osteoporosis or osteopenia. Hip fractures contributes to an already reduced mobility, while compression breaks, beyond pain and functional limitation, also contribute to increasing kyphosis of the thoracic spine, and develop an addition of a spirometric restrictive component and hence more breathing difficulties." p. 106
Complication of COPD
In section Symptoms and Treatment Measures at Terminal COPD, "The main distressing symptoms in advanced COPD include fatigue, shortness of breath, anorexia, depression, insomnia, pain and dry mouth/thirst." p. 117
Symptom of COPD
In section Opiates, "The main drugs for the relief of heavy breathing are opiates… The dosage of morphine is lower than in pain…." p. 118
Non-specific pain management-reference to opioid dose In section Appendix, Borg CR10 Scale, "Instruction: You should use this scale to tell how strong your experience or feeling is. It can apply your experience of effort, pain, difficulty or anything else." p. 143
Rating scale for pain assessment (non-specific context) In section Appendix, Borg CR10 Scale (explanation of the tool), "…The experience of the effort depends primarily on the fatigue in your muscles, whether you feel breathless and eventual pain." p. 144
Rating scale for pain assessment (non-specific context) Algeria [14] In the definition for Palliative Care, "Palliative care: Care aimed at alleviating symptoms, pain and distress, and hence improving quality of life, rather than at curing or slowing progression of a disease or condition. It is often associated with, but is actually not limited to, the end of life." p. 48
In section Symptoms, "Patients in whom a diagnosis of COPD is considered should also be asked about the presence of the following factors: chest pain." p. 63
Physician to assess for differential diagnosis (chest pain)
In section Symptoms of an Exacerbation, "Chest pain and fever are uncommon features of COPD exacerbations and should prompt a search for other aetiologies." p. 356
In section Oxygen Therapy during Exacerbations of COPD, "Radial stabs to obtain blood for arterial blood gas analysis are not more painful than arterialised ear lobe gases." p. 384
Lung function testing indication/contraindication (blood gas) In section Oxygen Therapy during Exacerbations of COPD "Arterialised ear lobe samples are an alternative way of obtaining arterial blood gases if there is local expertise and may be less painful for patients." p. 384
Lung function testing indication/contraindication (blood gas) 
10
In section Recommendation, "People with a mucus problem can be stimulated to be active and move in addition to other interventions. Using a simple questionnaire can get an impression of the problems that the patient experience and whether a reference here is useful: Questions concerning sputum retention: -Do you regularly cure (daily) mucus? -Can you easily cough or take a lot of effort? -How long are you coughing up in the morning? -Is it ever black for the eyes when coughing? -Are you very tired or short-tempered after coughing? -Is coughing painful? -Is the sputum tough?" p. 106
Questionnaire for assessment (painful cough for mucus clearance)
In section Quality of Life of People with COPD, "People with mild to moderate COPD treated in general practice score lower on almost all dimensions of quality of life, certainly in comparison with people with asthma. In the patient panel chronic diseases people with COPD were compared with people with other chronic disorders (not asthma) with regard to a number of important aspects of the chronic disease. The differences between the two groups are not large. However, COPD patients believe that the disease will progressively deteriorate, see more physical limitations, but experience less pain and are of the opinion that their disease can be better controlled by medical treatment than people with other chronic conditions (Patiëntenpanel, 2000) ." p. 124
Symptom of COPD
In section Quality of Life in Patients with COPD: Psychological Well-Being, Other Considerations, "If the patient experiences dyspnoea, the doctor should ask to what extent this leads to feelings of anxiety and worry (real or unreal). Also ask under which circumstances this is most common (ie physical exertion). Accompanying symptoms that the doctor asks about or in which he should think of the existence of an anxiety disorder are: palpitations, perspiration, tremor, pain, upset stomach, tingling, deaf feelings, heat or cold sensations, de-realization or depersonalization feelings, restlessness, being quickly tired, concentration problems, irritability, sleep problems. Depending on the severity, duration and course of the complaints, the influence Physician visit to assess for differential diagnosis (anxiety) on social functioning, and avoidance of certain situations or activities, the doctor decides whether targeted treatment is necessary." p. 129
In section Diagnosis for Lung Rehabilitation, Screening, Other considerations, "One problem with the screening lists is that lung patients often report thoracic pain. A complication is that exercise tests are not only time consuming, But also require expertise and medical supervision. Standard ergometric screening therefore rely heavily on capacity. For lung patients, (risk) groups should be defined based on the severity of the disorder (effort, desaturation), cardiovascular co-morbidity and training intensity." p. 190
Physician visit to assess for pulmonary rehabilitation
In Table 17 .2 Most important nuisance side effects of nicotine replacement drugs, "Chewing gum: Hiccups, gastrointestinal complaints, jaw pain, mouth-tooth complaints." p. 273
Drug adverse effects (nicotine replacement therapy)
In section Bupropion, "Side effects: Very common (>10%): insomnia. Common (1-10%): dry mouth, headache, dizziness, tremor, agitation, anxiety disorders, depression, difficulty concentrating, gastrointestinal disorders (such as nausea, vomiting, abdominal pain and constipation), taste disturbances, fever, perspiration, acute exanthema, itching, urticaria. Uncommon (0.1-1%): tachycardia, increased blood pressure (sometimes severe), flushing, chest pain, asthenia, anorexia, confusion, tinnitus, visual disturbances." p. 316
Drug adverse effects (smoking cessation aidBupropion)
In section Varenicline, "Side effects. Uncommon (0.1-1%): upper respiratory tract infections, throat irritation, hoarseness, mycosis, loss of appetite, anorexia, polydipsia, panic attack, bradyphrenia, abnormal thinking, mood swings, tremor, coordination disorders, dysarthria, hypertonia, restlessness, hypoaesthesia, hypoglyphosis , lethargy, asthenia, altered libido, menorrhagia, vaginal discharge, sexual dysfunction, cardiac arrhythmia, palpitations, visual disturbances, sclera discoloration, eye pain, increased tear production, photophobia, oral mucosal diseases, altered intestinal tract, abdominal pain, gastritis, gastroesophageal reflux, regurgitation, skin rash, itching, acne, increased perspiration, stiff joints, muscle spasms, costochondritis, snoring, 
In section Bronchodilators-Theophylline, "Significant undesirable effects of Theophylline therapy are nausea, vomiting, abdominal pain, sleep disorders, muscle cramps, hypokalaemia and tachycardic heart rhythm disturbances, which occasionally already at serum concentrations in the therapeutic range." p. 41
Drug adverse effects (methylxanthines)
